The interaction of bovine factor VIII with human platelets

Area of Science:

• Hematology
• Biochemistry
• Immunology

Background:

• Platelet aggregation is a critical process in hemostasis and thrombosis.
• Factor VIII is a key protein in the coagulation cascade, but its role in direct platelet interaction is less understood.

Purpose of the Study:

• To investigate the mechanisms by which bovine Factor VIII induces human platelet aggregation.
• To characterize the different types of aggregation caused by Factor VIII and identify factors influencing these reactions.

Main Methods:

• Human platelets were treated with purified bovine Factor VIII.
• Aggregation was assessed by light transmission, and specific conditions (calcium removal, formalin treatment, neuraminidase treatment) were employed to probe reaction pathways.
• Procoagulant and platelet-agglutinating activities were measured.

Main Results:

• Bovine Factor VIII induced three types of aggregation: primary agglutination, secondary aggregation (release reaction), and super-aggregation.
• The release reaction was inhibited by calcium removal or p-hydroxymercuriphenyl sulfonate, but primary agglutination and super-aggregation were not.
• Formalin-treated platelets aggregated with Factor VIII but not with ADP, thrombin, or collagen; neuraminidase treatment did not affect aggregation or procoagulant activity.

Conclusions:

• Bovine Factor VIII directly induces platelet aggregation via distinct mechanisms.
• Factor VIII's procoagulant and platelet-aggregating activities bind to the platelet surface during agglutination.
• The release reaction is calcium-dependent, while primary agglutination and super-aggregation are not.